Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Shock Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02979535
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 480
Early research (Phase 1)Study completedNCT01096576
What this trial is testing

Balapiravir in Patients With Dengue Virus Infection

Who this might be right for
Dengue
Hoffmann-La Roche 64
Post-approval studies (Phase 4)UnknownNCT02673840
What this trial is testing

Ketotifen as a Treatment for Vascular Leakage During Dengue Fever

Who this might be right for
Dengue FeverPleural Effusion
National University Hospital, Singapore 110
Early research (Phase 1)Study completedNCT00089908
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT01073306
What this trial is testing

Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

Who this might be right for
Dengue Virus
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00740155
What this trial is testing

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 154
Not applicableLooking for participantsNCT07007585
What this trial is testing

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Who this might be right for
DengueDengue FeverDengue Fever With Warning Signs
Jose Ivan Rodriguez de Molina Serrano 100
Testing effectiveness (Phase 2)Study completedNCT00880893
What this trial is testing

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 1,198
Not applicableActive Not RecruitingNCT06642493
What this trial is testing

Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
Sheikh Hasina National Institute of Burn and Plastic Surgery 300
Large-scale testing (Phase 3)Study completedNCT01254422
What this trial is testing

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi 250
Not applicableUnknownNCT01099852
What this trial is testing

Cohort of Patients Infected by an Arbovirus

Who this might be right for
FeverDengueChikungunya+1 more
University Hospital Center of Martinique 1,377
Early research (Phase 1)Study completedNCT01436422
What this trial is testing

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 112
Large-scale testing (Phase 3)Study completedNCT01373281
What this trial is testing

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 10,275
Early research (Phase 1)Study completedNCT00936429
What this trial is testing

Study of HBV-001 D1 in Healthy Adults

Who this might be right for
Dengue Fever
Hawaii Biotech, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01550289
What this trial is testing

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 189
Not applicableStudy completedNCT07621848
What this trial is testing

Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region

Who this might be right for
Dengue Fever
National Center for Gastroentestinal and Liver Disease 150
Early research (Phase 1)Study completedNCT00094705
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Study completedNCT01411241
What this trial is testing

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

Who this might be right for
DengueDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 720
Testing effectiveness (Phase 2)Study completedNCT00468858
What this trial is testing

Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
U.S. Army Medical Research and Development Command 636
Not applicableStudy completedNCT07205848
What this trial is testing

Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises

Who this might be right for
Dengue Hemorrhagic FeverAwareness
Research and Publication office 164
Next Page